SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Metropolis Healthcare lists with 9% premium on the BSE on debut

15 Apr 2019 Evaluate

Metropolis Healthcare has debuted at Rs 960.00 on the BSE, up by 80.00 point or 9.09% from its issue price of Rs 880.

The scrip is currently trading at Rs 942.80, up by 62.80 points or 7.14% from its issue price. It has touched a high and low of Rs 970.00 and Rs 934.80 respectively. So far 2,43,000 shares were traded on the counter.

The offering, which was open for subscription between April 03, 2019 and April 05, 2019, was subscribed 5.84 times. The issue price was fixed at Rs 880 per share i.e. at upper end of price band of Rs 877-880 apiece.

Metropolis Healthcare offers a comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.

Metropolis Health. Share Price

550.30 44.65 (8.83%)
08-May-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×